FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Hydromorphone Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-hydromorphone-hydrochloride-injection-hospira-inc-a-pfizer-company-0409-1304-31

Drug Shortage Details

Generic NameHydromorphone Hydrochloride Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryAnalgesia/Addiction
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-1304-31
Presentation & Dosage Form

Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.